| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a178904696794d1eb7bc8a1c26ece87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae1c9f8983dcf9271aef699839c63f82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2eecae1b04e7c0235060c68623ea71ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e0ba16fe396c0b97b1bcc3053630c98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ad41670a45f2c328911792e8080457b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-91097 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate |
2005-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b494fb0066d65e9bd07650468d7c86c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6c91a8880cd70d3ba831f668c917f0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e40ed0f606c468b6bd03a3a2f0c0fc2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91b477c4ae5bef487c5966375ec3e299 |
| publicationDate |
2006-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006066847-A1 |
| titleOfInvention |
Activator for insulin degrading enzyme |
| abstract |
The present invention relates to the use of Suramin in the manufacture of medicaments for treatment of neurodegenerative disorders, in particular of Alzheimer’s Disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3873461-A4 |
| priorityDate |
2004-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |